Clinical trial
Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma Activities
NCT00242814
Study timeline
Study start (actual)2005-11-03Date precision: day
Registry last updated2023-12-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hypertensionunresolved
Metabolic Syndrome Xunresolved
Interventions
MicardisDRUG · verified · RxNorm: Micardis
AmlodipineDRUG · verified · RxNorm: amlodipine
Abdominal biopsyPROCEDURE
Sponsors & collaborators
Boehringer Ingelheimlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00242814 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.